4//SEC Filing
Smith Edward F III 4
Accession 0001209191-19-008925
CIK 0001383701other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:20 PM ET
Size
9.8 KB
Accession
0001209191-19-008925
Insider Transaction Report
Form 4
Smith Edward F III
SVP, Reg Affairs and QA
Transactions
- Award
Stock Option (Right to Buy)
2019-02-07+100,000→ 100,000 totalExercise: $2.00Exp: 2029-02-06→ Common Stock (100,000 underlying) - Award
Common Stock
2018-11-14$3.15/sh+1,724$5,431→ 10,875 total - Award
Common Stock
2018-05-14$3.31/sh+4,690$15,524→ 9,151 total
Footnotes (4)
- [F1]These shares were acquired under the Company's 2013 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]In accordance with the Company's 2013 Employee Stock Purchase Plan, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 14, 2018, which was the last trading day of the applicable offering period.
- [F3]In accordance with the Company's 2013 Employee Stock Purchase Plan, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 15, 2018, which was the first trading day of the applicable offering period.
- [F4]The option was granted on February 7, 2019. 25% of the total number of shares of common stock subject to the option will vest on February 6, 2020, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeother
Related Parties
1- filerCIK 0001670699
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:20 PM ET
- Size
- 9.8 KB